Termination Agreement for Inducement Stock Option between The Immune Response Corporation and Robert E. Knowling, Jr.
The Immune Response Corporation and Robert E. Knowling, Jr. have agreed to immediately terminate Knowling's option to purchase 750,000 shares of the company's common stock, which was originally granted on February 9, 2005. This agreement is effective as of June 22, 2005, and ends all rights and obligations related to the stock option.
Exhibit 10.168.1
Termination of Inducement Stock Option
Reference is made to that certain option to purchase 750,000 shares of Common Stock of The Immune Response Corporation (the “Company”) that was granted to Robert E. Knowling, Jr. (“Knowling”) pursuant to the Inducement Stock Option Grant Notice dated February 9, 2005 (the “Option”).
The Company and Knowling agree that the Option is hereby terminated, effective immediately.
Dated: June 22, 2005
|
| The Immune Response Corporation | ||||
|
|
| ||||
|
| By: | /s/ Michael K. Green |
| ||
|
|
| Michael K. Green | |||
|
|
| Vice President, Finance and Chief Financial | |||
|
|
| ||||
|
|
| ||||
|
| /s/ Robert E. Knowling, Jr. |
| |||
|
| Robert E. Knowling, Jr. | ||||
